Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT 3 receptor antagonist, in ferrets

By Yoshikawa T.   Yoshida N.   Oka M.  

European Journal of Pharmacology, Vol. 431, Iss. 3, 2001-11 ,pp. : 361-364

Elsevier

Access to resources Recommend Favorite

The 5-HT 2 receptor antagonist, pelanserin, inhibits 1 -adrenoceptor-mediated vasoconstriction in vitro

By Villalobos-Molina R.   Ibarra M.   Hong E.  

European Journal of Pharmacology, Vol. 277, Iss. 2, 1995-04 ,pp. : 181-185

Elsevier

Access to resources Recommend Favorite

SDZ NVI 985, an 1A -adrenoceptor agonist with 5-HT 2A receptor antagonist properties

By Lachnit W.G.   Ford A.P.D.W.   Clarke D.E.  

European Journal of Pharmacology, Vol. 297, Iss. 1, 1996-02 ,pp. : 83-86

Elsevier

Access to resources Recommend Favorite

F15063, a potential antipsychotic with dopamine D₂/D₃ antagonist, 5-HT_1A agonist and D₄ partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

By Assié Marie-Bernadette   Bardin Laurent   Auclair Agnès   Consul-Denjean Nathalie   Sautel François   Depoortère Ronan   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 4, 2007-06 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite

In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT 1B/1D/2 receptor antagonist properties

By Pullar I.A.   Boot J.R.   Carney S.L.   Cohen M.L.   Colvin E.M.   Conway R.G.   Hardy C.H.L.   Lucaites V.L.   Nelson D.L.   Schenck K.W.   Tomlinson R.   Wedley S.  

European Journal of Pharmacology, Vol. 432, Iss. 1, 2001-11 ,pp. : 9-17

Elsevier

Access to resources Recommend Favorite